secwatch.observer — SEC 8-K summary
======================================

Issuer:     Claritev Corp (CTEV)
CIK:        0001793229
Form:       8-K
Filed at:   2026-10-15T13:03:37+00:00
Accession:  0001793229-26-000077
Event type: leadership
Sentiment:  neutral
Materiality: 0.20
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4.1-flash:cloud@v2

Claritev adds Jennifer Main to board; ex-CMS COO and TARP CFO takes new Class II seat
--------------------------------------------------------------------------------

- Board expanded from 11 to 12 directors; Main appointed to the newly created Class II directorship effective October 15, 2026, and joins the Audit Committee.
- Concurrently, Mr. Jason Kap ceased serving as a member of the Audit Committee; no other committee changes disclosed.
- Main is CFO of RealMDai (dba Certuma) and Overture Life since March 2026; previously CFO and COO of Amalgam Rx from 2021 to 2026.
- She was Chief Operating Officer of the Centers for Medicare & Medicaid Services from 2018 to 2021, overseeing Medicare, Medicaid and marketplace programs, and CFO of Treasury's $700 billion TARP.
- Compensation follows the non-employee director policy in the March 20, 2026 proxy; she will enter the company's standard indemnification agreement. No related-party transactions disclosed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1793229/000179322926000077/0001793229-26-000077-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1793229/000179322926000077/ctev-20261015.htm
  HTML page:      https://secwatch.observer/filing/0001793229-26-000077

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer